# Precipio, Inc.: financial statements, quarterly

PRPO · Nasdaq · CIK 1043961 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prpo.md) · [Financials](/companies/prpo/financials.md) · [Filings](/companies/prpo/filings.md) · [Insiders](/companies/prpo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/prpo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [4,569](/filings/0001558370-24-014619.md) | [4,372 d](/filings/0001558370-25-003817.md) | [3,478](/filings/0001558370-25-007776.md) | [4,507](/filings/0001558370-25-011390.md) | [5,280](/filings/0001104659-25-112601.md) | [5,311 d](/filings/0001104659-26-036878.md) | [4,911](/filings/0001104659-26-061188.md) | [5,629](/filings/0001104659-26-097047.md) | [6,885](/filings/0001104659-25-112601.md) | [6,821 d](/filings/0001104659-26-036878.md) | [6,961](/filings/0001104659-26-061188.md) | [7,021](/filings/0001104659-26-097047.md) |
| Cost of revenue | $k | [2,633](/filings/0001558370-24-014619.md) | [2,316 d](/filings/0001558370-25-003817.md) | [2,512](/filings/0001558370-25-007776.md) | [2,725](/filings/0001558370-25-011390.md) | [2,932](/filings/0001104659-25-112601.md) | [2,804 d](/filings/0001104659-26-036878.md) | [2,789](/filings/0001104659-26-061188.md) | [3,225](/filings/0001104659-26-097047.md) | [3,762](/filings/0001104659-25-112601.md) | [3,567 d](/filings/0001104659-26-036878.md) | [3,986](/filings/0001104659-26-061188.md) | [3,885](/filings/0001104659-26-097047.md) |
| Gross profit | $k | [1,885](/filings/0001558370-24-014619.md) | [2,013 d](/filings/0001558370-25-003817.md) | [920](/filings/0001558370-25-007776.md) | [1,716](/filings/0001558370-25-011390.md) | [2,277](/filings/0001104659-25-112601.md) | [2,646 d](/filings/0001104659-26-036878.md) | [2,140](/filings/0001104659-26-061188.md) | [2,429](/filings/0001104659-26-097047.md) | [3,005](/filings/0001104659-25-112601.md) | [3,132 d](/filings/0001104659-26-036878.md) | [2,725](/filings/0001104659-26-061188.md) | [3,136](/filings/0001104659-26-097047.md) |
| Research and development | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(1,448)](/filings/0001558370-24-014619.md) | [(854) d](/filings/0001558370-25-003817.md) | [(2,074)](/filings/0001558370-25-007776.md) | [(1,209)](/filings/0001558370-25-011390.md) | [(597)](/filings/0001104659-25-112601.md) | [(336) d](/filings/0001104659-26-036878.md) | [(859)](/filings/0001104659-26-061188.md) | [(824)](/filings/0001104659-26-097047.md) | [(61.0)](/filings/0001104659-25-112601.md) | [542 d](/filings/0001104659-26-036878.md) | [(1,428)](/filings/0001104659-26-061188.md) | [(599)](/filings/0001104659-26-097047.md) |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(1,455)](/filings/0001558370-24-014619.md) | [925 d](/filings/0001558370-25-003817.md) | [(2,079)](/filings/0001558370-25-007776.md) | [(1,220)](/filings/0001558370-25-011390.md) | [(626)](/filings/0001104659-25-112601.md) | [(365) d](/filings/0001104659-26-036878.md) | [(884)](/filings/0001104659-26-061188.md) | [74.0](/filings/0001104659-26-097047.md) | [(79.0)](/filings/0001104659-25-112601.md) | [526 d](/filings/0001104659-26-036878.md) | [(1,443)](/filings/0001104659-26-061188.md) | [(219)](/filings/0001104659-26-097047.md) |
| Diluted EPS | $ per share | [(1.04)](/filings/0001558370-24-014619.md) | not reported | [(1.46)](/filings/0001558370-25-007776.md) | [(0.83)](/filings/0001558370-25-011390.md) | [(0.42)](/filings/0001104659-25-112601.md) | not reported | [(0.59)](/filings/0001104659-26-061188.md) | [0.05](/filings/0001104659-26-097047.md) | [(0.05)](/filings/0001104659-25-112601.md) | not reported | [(0.81)](/filings/0001104659-26-061188.md) | [(0.12)](/filings/0001104659-26-097047.md) |
| Basic EPS | $ per share | [(1.04)](/filings/0001558370-24-014619.md) | not reported | [(1.46)](/filings/0001558370-25-007776.md) | [(0.83)](/filings/0001558370-25-011390.md) | [(0.42)](/filings/0001104659-25-112601.md) | not reported | [(0.59)](/filings/0001104659-26-061188.md) | [0.05](/filings/0001104659-26-097047.md) | [(0.05)](/filings/0001104659-25-112601.md) | not reported | [(0.81)](/filings/0001104659-26-061188.md) | [(0.12)](/filings/0001104659-26-097047.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: not reported
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.6](/filings/0001558370-23-018820.md) | [1.5](/filings/0001558370-25-003817.md) | [0.8](/filings/0001558370-24-008128.md) | [1.3](/filings/0001558370-24-012053.md) | [1.1](/filings/0001558370-24-014619.md) | [1.4](/filings/0001104659-26-036878.md) | [1.0](/filings/0001558370-25-007776.md) | [1.1](/filings/0001558370-25-011390.md) | [2.3](/filings/0001104659-25-112601.md) | [2.7](/filings/0001104659-26-097047.md) | [2.6](/filings/0001104659-26-061188.md) | [3.1](/filings/0001104659-26-097047.md) |
| Current assets | $m | [4.3](/filings/0001558370-23-018820.md) | [3.7](/filings/0001558370-25-003817.md) | [2.6](/filings/0001558370-24-008128.md) | [3.4](/filings/0001558370-24-012053.md) | [3.3](/filings/0001558370-24-014619.md) | [3.5](/filings/0001104659-26-036878.md) | [3.3](/filings/0001558370-25-007776.md) | [4.1](/filings/0001558370-25-011390.md) | [5.7](/filings/0001104659-25-112601.md) | [6.0](/filings/0001104659-26-097047.md) | [5.9](/filings/0001104659-26-061188.md) | [6.5](/filings/0001104659-26-097047.md) |
| Total assets | $m | [19.1](/filings/0001558370-23-018820.md) | [18.1](/filings/0001558370-25-003817.md) | [16.6](/filings/0001558370-24-008128.md) | [17.3](/filings/0001558370-24-012053.md) | [17.0](/filings/0001558370-24-014619.md) | [17.0](/filings/0001104659-26-036878.md) | [17.8](/filings/0001558370-25-007776.md) | [18.8](/filings/0001558370-25-011390.md) | [21.2](/filings/0001104659-25-112601.md) | [21.3](/filings/0001104659-26-097047.md) | [20.8](/filings/0001104659-26-061188.md) | [21.3](/filings/0001104659-26-097047.md) |
| Current liabilities | $m | [5.5](/filings/0001558370-23-018820.md) | [3.1](/filings/0001558370-25-003817.md) | [3.3](/filings/0001558370-24-008128.md) | [4.6](/filings/0001558370-24-012053.md) | [4.5](/filings/0001558370-24-014619.md) | [4.3](/filings/0001104659-26-036878.md) | [4.3](/filings/0001558370-25-007776.md) | [4.4](/filings/0001558370-25-011390.md) | [4.5](/filings/0001104659-25-112601.md) | [3.8](/filings/0001104659-26-097047.md) | [3.8](/filings/0001104659-26-061188.md) | [3.7](/filings/0001104659-26-097047.md) |
| Total liabilities | $m | [6.1](/filings/0001558370-23-018820.md) | [3.7](/filings/0001558370-25-003817.md) | [3.9](/filings/0001558370-24-008128.md) | [5.2](/filings/0001558370-24-012053.md) | [5.0](/filings/0001558370-24-014619.md) | [4.9](/filings/0001104659-26-036878.md) | [6.1](/filings/0001558370-25-007776.md) | [6.5](/filings/0001558370-25-011390.md) | [7.4](/filings/0001104659-25-112601.md) | [6.8](/filings/0001104659-26-097047.md) | [6.6](/filings/0001104659-26-061188.md) | [6.6](/filings/0001104659-26-097047.md) |
| Long-term debt | $m | [0.1](/filings/0001558370-23-018820.md) | [0.1](/filings/0001558370-25-003817.md) | [0.1](/filings/0001558370-24-008128.md) | [0.1](/filings/0001558370-24-012053.md) | [0.1](/filings/0001558370-24-014619.md) | [0.1](/filings/0001104659-26-036878.md) | [0.1](/filings/0001558370-25-007776.md) | [0.1](/filings/0001558370-25-011390.md) | [0.1](/filings/0001104659-25-112601.md) | [0.0](/filings/0001104659-26-097047.md) | [0.0](/filings/0001104659-26-061188.md) | [0.3](/filings/0001104659-26-097047.md) |
| Current portion of debt | $m | [0.3](/filings/0001558370-23-018820.md) | [0.2](/filings/0001558370-25-003817.md) | [0.1](/filings/0001558370-24-008128.md) | [0.2](/filings/0001558370-24-012053.md) | [0.4](/filings/0001558370-24-014619.md) | [0.3](/filings/0001104659-26-036878.md) | [0.1](/filings/0001558370-25-007776.md) | [0.0](/filings/0001558370-25-011390.md) | [0.0](/filings/0001104659-25-112601.md) | [0.0](/filings/0001104659-26-097047.md) | [0.0](/filings/0001104659-26-061188.md) | [0.1](/filings/0001104659-26-097047.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [12.9](/filings/0001558370-23-018820.md) | [14.4](/filings/0001558370-24-004365.md) | [12.8](/filings/0001558370-25-011390.md) | [12.1](/filings/0001104659-25-112601.md) | [11.9](/filings/0001104659-25-112601.md) | [12.1](/filings/0001104659-26-097047.md) | [11.7](/filings/0001104659-26-097047.md) | [12.3](/filings/0001104659-26-097047.md) | [13.7](/filings/0001104659-25-112601.md) | [14.6](/filings/0001104659-26-097047.md) | [14.2](/filings/0001104659-26-097047.md) | [14.8](/filings/0001104659-26-097047.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(896) d](/filings/0001558370-24-014619.md) | [114 d](/filings/0001558370-25-003817.md) | [(667)](/filings/0001558370-25-007776.md) | [500 d](/filings/0001558370-25-011390.md) | [41.0 d](/filings/0001104659-25-112601.md) | [565 d](/filings/0001104659-26-036878.md) | [(44.0)](/filings/0001104659-26-061188.md) | [353 d](/filings/0001104659-26-097047.md) | [10.0 d](/filings/0001104659-25-112601.md) | [366 d](/filings/0001104659-26-036878.md) | [64.0](/filings/0001104659-26-061188.md) | [660 d](/filings/0001104659-26-097047.md) |
| Capital expenditure | $k | [23.0 d](/filings/0001558370-24-014619.md) | [49.0 d](/filings/0001558370-25-003817.md) | not reported | not reported | [109 d](/filings/0001104659-25-112601.md) | [44.0 d](/filings/0001104659-26-036878.md) | [138](/filings/0001104659-26-061188.md) | [59.0 d](/filings/0001104659-26-097047.md) | [54.0 d](/filings/0001104659-25-112601.md) | [75.0 d](/filings/0001104659-26-036878.md) | [50.0](/filings/0001104659-26-061188.md) | [132 d](/filings/0001104659-26-097047.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q3 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [1,138](/filings/0001558370-23-018820.md) | [1,161](/filings/0001558370-24-008128.md) | [1,218](/filings/0001558370-24-012053.md) | [1,395](/filings/0001558370-24-014619.md) | [1,424](/filings/0001558370-25-007776.md) | [1,464](/filings/0001558370-25-011390.md) | [1,480](/filings/0001104659-25-112601.md) | [1,503](/filings/0001104659-26-061188.md) | [1,602](/filings/0001104659-26-097047.md) | [1,637](/filings/0001104659-25-112601.md) | [1,783](/filings/0001104659-26-061188.md) | [1,787](/filings/0001104659-26-097047.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,790,188 at 2026-08-10, from the cover of the [10-Q filed 2026-08-14](/filings/0001104659-26-097047.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.